SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending intensely as the community eagerly awaits the imminent launch of its next-generation BlueBird 6 satellite, seen as a crucial "scale-up proof point" for its space-based cellular network. The "SpaceMob" is buzzing with excitement, discussing the company's long-term potential and market impact, with many dismissing concerns that the event is already "priced in." This highly anticipated launch is generating strong bullish sentiment, positioning ASTS as a key player in the evolving space sector.

Ascent Solar Technologies, Inc. engages in the design, development, and manufacture of solar technology and power solutions for remote locations and extreme environments. It integrates photovoltaic modules into a variety of applications such as aerospace, defense, transportation, and electronic products. The company was founded by Mohan S. Misra and Joseph H. Armstrong on October 18, 2005 and is headquartered in Thornton, CO.

Ascent Solar Technologies Inc

Ascent Solar Technologies is generating buzz following a series of strategic teaming agreements that position its specialized thin-film solar technology for critical applications across the growing space, aerospace, and defense sectors. The community is actively debating the stock's high volatility and long-term potential for significant contracts, with discussions weighing its innovative solar solutions for lunar missions and drone powering against concerns about its historical dilution.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X (CCCX) is drawing significant attention as its merger target, Infleqtion, continues to announce strategic partnerships and accolades for its commercially viable quantum sensing and computing technologies. The community is actively discussing Infleqtion's perceived undervaluation against sector peers, with many anticipating a substantial re-rating and increased institutional interest once the de-SPAC process concludes and the ticker changes to INFQ.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is generating buzz due to key advancements, including plans to double U.S. manufacturing capacity and initiating pre-commercial air taxi evaluations in Saudi Arabia, building on its recent successful piloted flight in Dubai. Amidst intense sector competition, community discussion also focuses on a lawsuit against a rival and a notable "Sell" rating from a prominent investment bank, with many investors maintaining a bullish long-term outlook on the burgeoning eVTOL market.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is actively trending following news of its strategic expansion, including partnerships with US cities for air taxi trials under a new White House initiative, the acquisition of Hawthorne Airport as a key LA hub, and an agreement with Saudi Arabia for eVTOL deployment. The community is sharply divided, with bulls anticipating a significant breakout in 2026 fueled by these developments and decreasing short interest, while skeptics remain concerned about execution timelines and potential dilution for the pre-revenue company.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is trending intensely as investors eagerly await the imminent FDA decision for Narsoplimab, its drug for transplant-associated thrombotic microangiopathy (TA-TMA), following the recent closing of a substantial licensing deal with Novo Nordisk. The community is buzzing with speculation on approval timing and potential post-decision price action, with many anticipating a significant upward move due to the drug's critical unmet medical need, a substantial share buyback program, and high short interest.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore Corp. is trending after receiving federal regulatory approval to restart its Las Flores Pipeline System, a move perceived as a crucial step toward reactivating its California offshore oil assets under federal oversight. This development has spurred significant community discussion, with many investors anticipating substantial upside and a potential short squeeze, while others remain cautious due to the company's financial concerns and the likelihood of continued state-level legal and permitting challenges.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending higher following significant insider buying, notably from Apple CEO and Nike board member Tim Cook, who acquired a substantial amount of shares. This high-profile purchase, coupled with the stock trading at multi-year lows, is fueling community optimism for a potential turnaround despite ongoing discussions about pressures from tariffs and weaker demand in China.

ProShares Trust - ProShares Ultra Bitcoin ETF

ProShares Ultra Bitcoin ETF

ProShares Ultra Bitcoin ETF ($BITU) is trending after a significant price adjustment, which the community widely attributes to its ex-dividend date for a cash distribution rather than a fundamental market event. Initial investor confusion and concerns about a halt or crash quickly gave way to reassurances that the drop is a mechanical adjustment for the dividend, with some viewing this as a buying opportunity. This highlights the specific operational characteristics of leveraged ETFs as investors navigate its movements.

Ramaco Resources, Inc. engages in the operation and development of coal mining properties. The firm deals with metallurgical coal in central and southern West Virginia, southwestern Virginia and southwestern Pennsylvania. Its portfolio consists of Elk Creek, Berwind, RAM Mine, and Knox Creek. The company was founded by Randall W. Atkins in August 2015 and is headquartered in Lexington, KY.

Ramaco Resources Inc - Ordinary Shares - Class A

Ramaco Resources Inc

Ramaco Resources (METC) is a major talking point following key strategic partnerships with the U.S. Department of Energy and Goldman Sachs to establish a national critical minerals stockpile, alongside significantly expanded rare earth production targets at its Brook Mine. The community is vigorously debating the stock's high short interest and perceived undervaluation, anticipating a substantial re-rating as the U.S. prioritizes building a domestic supply chain for critical rare earth elements.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Acadian Asset Management LLC Boosts Position in Anika Therapeutics Inc. $ANIK

Acadian Asset Management LLC lifted its position in shares of Anika Therapeutics Inc. (NASDAQ:ANIK - Free Report) by 6.7% in the second quarter, according to its most recent filing with the...

Anika Therapeutics (NASDAQ:ANIK) Upgraded at Wall Street Zen

Wall Street Zen upgraded Anika Therapeutics from a "hold" rating to a "buy" rating in a research report on Saturday...

Barrington Research Forecasts Strong Price Appreciation for Anika Therapeutics (NASDAQ:ANIK) Stock

Barrington Research increased their price target on shares of Anika Therapeutics from $15.00 to $16.00 and gave the company an "outperform" rating in a research note on Thursday...

Anika Therapeutics (NASDAQ:ANIK) Releases Quarterly Earnings Results, Misses Estimates By $0.19 EPS

Anika Therapeutics (NASDAQ:ANIK - Get Free Report) issued its quarterly earnings results on Wednesday. The biotechnology company reported ($0.17) earnings per share (EPS) for the quarter, missing the...

Anika Therapeutics (ANIK) Q3 Earnings and Revenues Top Estimates

Anika (ANIK) delivered earnings and revenue surprises of +100.00% and +0.06%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Arcturus Therapeutics (ARCT) Surges 8.7%: Is This an Indication of Further Gains?

Arcturus Therapeutics (ARCT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Wall Street Analysts See a 98.59% Upside in Anika (ANIK): Can the Stock Really Move This High?

The consensus price target hints at a 98.6% upside potential for Anika (ANIK). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Anika (ANIK) Upgraded to Buy: Here's What You Should Know

Anika (ANIK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates

Anika (ANIK) delivered earnings and revenue surprises of 0.00% and +4.32%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

uniQure (QURE) Reports Q2 Loss, Misses Revenue Estimates

uniQure (QURE) delivered earnings and revenue surprises of +22.47% and -26.23%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.12	--	--	N/A
Q3 '25	-$0.18	$0.04	122.22%	BEAT
Q2 '25	-$0.26	-$0.13	50.63%	BEAT
Q1 '25	-$0.09	-$0.06	33.33%	BEAT
Q4 '24	-$0.22	-$0.03	86.67%	BEAT

ANIK
Anika Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest ANIK News

ANIKAnika Therapeutics Inc.